Users should not expect the appetite reduction that comes with compounds like semaglutide or tirzepatide
You can gain extraordinary insight with our complimentary consultation backed by more than 30 years of experience.
Lose 14-15% of your body weight* *In clinical trials of Wegovy (FDA-approved semaglutide), participants achieved an average weight loss of approximately 15% over 68 weeks, with some participants achieving up to 20% with continued treatment and adherence, when combined with diet and exercise
Maintaining healthy levels of Vitamin B12 can help prevent a number of cognitive and metabolic disorders that cost money and dramatically reduce your quality of life
Many weight loss approaches either leave you fighting intense appetite stimulation or relying on appetite suppressants that fundamentally alter your relationship with food
This is one reason MOTS-c is frequently discussed in longevity, performance, and metabolic-health communities